"Cardiac
and Lung Surgical Robots: Market Shares, Strategy, and Forecasts,
Worldwide, 2015 to 2021"
The Report covers current Industries Trends, Worldwide Analysis,
Global Forecast, Review, Share, Size, Growth, Effect.
Description-
The
2015 study has 223 pages, 85 tables and figures. Worldwide Cardiac
and Lung surgical robot markets are poised to achieve significant
growth as next generation systems provide a way to improve
traditional open surgery and decrease the number of ports needed for
minimally invasive surgery.
The
automated process revolution in surgery and communications is being
implemented via robots. Robots automation of systems is providing
significant improvement in the accuracy of surgery and the
repeatability of process.
Intuitive
Surgical owns the market as the major participant with compelling
market share in cardiac and lung surgical robots. This leadership
position will need to be defended as other vendor products, now in
clinical trials come to market. Advanced technology, an installed
base and a well trained core group of surgeons give Intuitive
Surgical market advantage.
Patients for some types of procedures fare better
when the heart or lung surgery is done by surgical robots. The
documentation of improvements in care delivery, the ability to ensure
better outcomes from surgery promise that cardiac and lung surgical
robotics is a strong growth market.
Heart disease is still the largest disease
worldwide. The issue for cardiac and lung robotic surgery is that so
many heart patients exist.
Every leading surgeon working to perform heart
and lung robotic surgery has worked to be accepted to practice at a
hospital that has those robotic devices. The really talented surgeons
depend on hospitals having the cardiac robotic equipment. In order to
attract physicians and patients, the hospitals have to purchase the
surgical equipment.
The market penetration of the cardiac and lung
surgical robots will go to 100 percent in the US top hospitals within
five years. As the surgeons migrate to the places that have the
robotic surgical equipment, other hospitals and their potential
patient populations notice. If the hospital does not have the
surgical robotic equipment, it will not have any surgeons, this is a
bad situation for a hospital. The cardiac and lung robotic surgical
equipment permits better surgery and the surgeons and patients know
this.
Cardiac and lung robotic surgery is poised to
eclipse open surgery. It is used in the categories of lobectomy,
thoracic revascularization, and mitral valve repair surgery. Surgical
robots are positioned to become the standard of care for hospitals in
the delivery of some heart surgery. The emerging group of several
surgical robotic companies will collectively have enough marketing
dollars and enough marketing clout to drive replacement of virtually
all open cardiac and lung surgery.
Larger hospitals that can afford the
expenditure are adopting heart and lung robotic surgical devices to
improve their outcomes numbers. Hospitals are measured on outcomes,
robots for surgery, when used by a trained physician are improving
outcomes significantly. Hospital robotic systems have an emphasis on
outcomes improvement during surgery. This has resulted in investment
in robotics technology that is useful, and achieves positive patient
outcomes.
Technology is enhancing a wide variety of
procedures in many cardiac surgical specialties. Cardiac and thoracic
surgeons at leading hospitals use robotic surgical systems
increasingly. The aim is to perform more of the one-hundred thousand
MIS surgical procedures of various types using robots. The surgeries
performed by robot include cardiothoracic and vascular surgery. These
surgical applications are cleared by the FDA.
The technology uses
metal tubes attached to the arms are inserted through the ports, and
the cutting and visualization instruments are introduced through the
tubes into the patient’s body. The surgeon performs the procedure
while sitting at a console, manipulating the instrument controls and
viewing the operation through a vision system. When a surgeon needs
to change an instrument the instrument is withdrawn from the surgical
field using the controls at the console and the nursing assistants
switch instruments as per the physician instruction. This is done
many times during an operation.
The cardiac and lung surgical
robot market is characterized enormous variety and innovation. A
surgical robot recurring revenue business model is essentially a
large one time purchase for a system complimented by replaceable or
disposable instruments that cumulatively make the market a much
larger and sustainable ongoing market. Vendors make money from the
one time sale of a system and recurring revenue from sale of devices
used in every operation.
Initially, a vendor sells and installs the
surgical system into new customer accounts. Once systems are sold
into customer accounts, the vendor generates recurring revenue as
customers use the system to perform surgery. To do cardiac and lung
robotic surgeries, the customers need to buy and consume instruments
and accessory products. Vendors also generate recurring revenue from
system service.
“Existing open cardiac and lung surgery can
be replaced in some part by robotic surgery during the forecast
period. Cardiac and lung robotic surgical approaches complement
existing open surgery techniques. Soon, all surgery will be
undertaken with at least come aspects of robotic surgery replacing or
complementing open surgery.”
The aging US population has
supported demand, since the occurrence of health issues that require
medical devices is higher in the elderly population. Buoyed by strong
demand and sales, industry profit margins have increased considerably
during the past five years.
Hospitals are adopting robotic
surgical devices to improve their outcomes numbers. Hospitals are
measured on outcomes, robots for surgery, when used by a trained
physician are improving outcomes significantly. Hundreds of
universities worldwide have research programs in robotics and many
are awarding degrees in robotics. These “roboticists” are
increasingly being hired by Global 2000 organizations to link mobile
robots (mobile computers) into existing IT systems.
Robot-assisted surgery gives the surgeon
better control over the surgical instruments and a better view of the
surgical site. Surgeons no longer have to stand throughout the
surgery and do not tire as quickly. Hand tremors are filtered out by
the robot’s computer software. The surgical robot can continuously
be used by rotating surgery teams. 3D viewing of the surgical site on
a large screen improves visualization of the surgical operating
field.
Cardiac and lung surgical robot device markets at $72.2
million in 2014 are anticipated to reach $2.2 billion by 2021 as next
generation devices, systems, and instruments are introduced to manage
surgery through small ports in the body instead of large open wounds.
The complete report provides a comprehensive
analysis including procedure numbers, units sold, market value,
forecasts, as well as a detailed competitive market shares and
analysis of major players’ success, challenges, and strategies in
each segment and sub-segment. The reports cover markets for Cardiac
and Lung robotic surgery medical specialties and sub-specialties.
–
Companies Profiled
Intuitive Surgical
– Market Participants
Chinese Surgical
Robots
Corindus
Freehand
Johnson and
Johnson / DePuy Synthes
Google / Johnson &
Johnson / Ethicon
Medrobotics
Medtronic
Meerecompany /
Eterne
Titan Medical
TransEnterix Acquires the ALF-X Surgical
Robotic System
– Table
of Contents
– Heart and Lung Surgical Robot Executive
Summary 21
– Heart and Lung Surgical Robot Executive
Summary 21
Heart
and Lung Surgical Robot Market Driving Forces 21
Surgical Robotics
Market Driving Forces 22
Cardiac Surgical Robot Key Procedures As
Elements Of Strategy 24
Cardiac and Lung Surgical Robots Market
Share Analysis 25
Cardiac and Lung Surgical Robot Market Forecasts
27
– 1. Cardiac Surgical Robot Market
Description and Market Dynamics 30
1.1 Cardiac Robotic
Surgical Clinical Applications 30
1.1.1 Robotic Cardiothoracic
Surgery 33
1.1.2 Mitral Valve Repairs Are Preferred Over Mitral
Valve Replacement 33
1.1.3 Mitral Valve Repair 34
1.1.4 Mitral
Valve Replacement Possible Complications 36\
1.2 Interventional
Cardiologists Treatments and Procedures 39
1.3 Robotic Internal
Thoracic Artery Dissection 40
1.3.1 Robotic Thoracoscopy 41
1.3.2
Cardiothoracic Surgery 42
1.4 Surgical Robotic Lobectomy 42
1.5
Robotic Coronary Artery Bypass 43
– 2. Heart and Lung Surgical Robot
Market Shares and Market Forecasts 45
2.1 Heart and Lung
Surgical Robot Market Driving Forces 45
2.1.1 Surgical Robotics
Market Driving Forces 46
2.1.1 Cardiac Surgical Robot Key
Procedures As Elements Of Strategy 49
2.2 Cardiac and Lung
Surgical Robots Market Share Analysis 50
2.2.1 Intuitive Surgical
da Vinci™ Surgical System Is Food and Drug Administration (FDA)
Approved Cardiac and Lung Robotic System 53
2.2.2 Corindus
54
2.2.3 MedRobotics 55
2.3 Cardiac and Lung Surgical Robot
Market Forecasts 56
2.4 Cardiac and Lung Surgical Robot Installed
Systems and Procedure Volumes by Country 60
2.5 Key Players In The
Global Medical Surgical Robots Market 66
2.6 Robotic Surgery
Equipment Prices 66
2.1.2 Intuitive Surgical da Vinci Surgical
System Prices 67
2.7 Cardiac and Lung Robotic Surgery Equipment
Regional Market Segments 68
2.7.1 Intuitive Surgical Regional
Revenue 71
2.7.2 Intuitive Surgical European Demand 72
2.7.3
Intuitive Surgical in Japan 72
2.7.4 U.S. Robotic Surgical
Procedures 72
2.7.5 BRIC (Brazil, Russia, India, China) countries
73
2.7.6 Aging Taiwanese Population 73
2.7.7 Korea Focusing On
Creating A Growth Engine In Research & Development 74
2.7.8
Korea 74
2.7.9 Brazil 75
2.7.10 Chinese Imported Surgical
Robots 75
2.7.11 Chinese Development of Surgical Robots 76
2.8
Chinese Robotic Cardiac Surgery 77
2.8.1 Chinese Robotic Cardiac
Team Recognized As One Of World's Best 77
– 3. Cardiac Surgical Robots Product
Descriptions 80
3.1 Intuitive Surgical Cardiothoracic
Surgeries 80
3.1.1 Intuitive Surgical da Vinci Surgical System
82
3.1.2 Intuitive Surgical Da Vinci Minimally Invasive Surgical
Product 83
3.1.3 Intuitive Surgical Cardiac Surgery 84
3.1.4
Intuitive Surgical da Vinci Surgical System Components 90
3.1.5
Intuitive Surgical Patient-Side Cart and Electromechanical Surgical
Arms 94
3.1.6 Intuitive Surgical 3-D Vision System 94
3.1.7
Intuitive Surgical Firefly Fluorescence Imaging 95
3.1.8 Intuitive
Surgical. da Vinci Surgical System EndoWrist® Instruments 96
3.1.9
Intuitive Surgical Instruments and Accessories 98
3.1.10 Intuitive
Surgical da Vinci Single-Site 99
3.1.11 Intuitive Surgical
EndoWrist One Vessel Sealer 99
3.1.12 Intuitive Surgical da Vinci
Skills Simulator 104
3.2 Titan Medical 105
3.3 Johnson &
Johnson 109
3.3.1 Johnson & Johnson Ethicon 110
3.4
MedRobotics 112
3.4.1 Medrobotics Flex® Retractor 114
3.4.2
Medrobotics Flexible Robot Platform 115
3.4.3 Medrobotics
Snakelike Robots for Oropharynx, Hypopharynx and Larynx
Surgery116
3.5 Corindus 119
3.5.1 CorPath Robotic Angioplasty
120
3.5.2 Corindus Command. Control CorPath® 200 System 121
3.5.3
Corindus Standard in Precision PCI 123
3.5.4 Robotic Angioplasty /
Interventional Cardiology 127
3.6 Changzhou Kangxin Medical
Instruments Co., Ltd. 128
3.7 Guangzhou Baitang Medical Instrument
Co., Ltd. 128
– 4. Cardiac Surgical Robots Technology
and Research 129
4.1 Intuitive Surgical Da Vinci
Computerized Technology For Surgery 129
4.2 Intuitive Surgical da
Vinci Xi Surgical System Minimally Invasive Surgery 130
4.2.1
Intuitive Surgical da Vinci Surgical System 131
4.3 Third Party
Reimbursement 132
– 5. Cardiac and Lung Surgical Robots
Company Descriptions 135
5.1 Chinese Surgical Robots
135
5.2 Corindus 139
5.2.1 Corindus Benefits of CorPath
Robotic-Assisted PCI 142
5.2.2 Corindus Improves Staff Position in
the Room 143
5.3 Freehand 144
5.3.1 Freehand 2010 / Prosurgics
145
5.4 Intuitive Surgical 145
5.4.1 Intuitive Surgical
Robotics da Vinci® Surgical System 151
5.4.2 Intuitive Surgical
Robotics da Vinci Surgical System Xi 152
5.4.3 Intuitive Surgical
Business Strategy 154
5.4.4 Intuitive Surgical Systems 157
5.4.5
Intuitive Surgical Patient Value As Equal To Procedure Efficacy /
Invasiveness 157
5.4.6 Intuitive Surgical Business Model 158
Comments
Post a Comment